Sandbox spb2013: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 34: | Line 34: | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[ESA guidelines classification scheme#Classification of Recommendations|Class 1]] | | colspan="1" style="text-align:center; background:LightGreen"|[[ESA guidelines classification scheme#Classification of Recommendations|Class 1]] | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' We recommend that acute [[variceal bleeding]] should be managed by a multidisciplinary team. A specific multimodal protocol for [[upper gastrointestinal hemorrhage]] should be available | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' We recommend that acute [[variceal bleeding]] should be managed by a multidisciplinary team. A specific multimodal protocol for [[upper gastrointestinal hemorrhage]] should be available. ''([[ESA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.''' We recommend that early treatment involves immediate use of [[vasopressor]]s ([[somatostatin]] or [[terlipressin]]) to reduce [[bleeding]] and early interventional [[endoscopy]]. [[Antibiotic]]s must be started on admission. ''([[ESA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''<nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.''' We recommend that early treatment involves immediate use of [[vasopressor]]s ([[somatostatin]] or [[terlipressin]]) to reduce [[bleeding]] and early interventional [[endoscopy]]. [[Antibiotic]]s must be started on admission. ''([[ESA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''<nowiki>"</nowiki> | ||
| Line 52: | Line 52: | ||
|} | |} | ||
===Pediatric Surgery=== | |||
{|class="wikitable" style="width: 80%;" | |||
|- | |||
| colspan="1" style="text-align:center; background:LightGreen"|[[ESA guidelines classification scheme#Classification of Recommendations|Class 1]] | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' We recommend against the use of rFVIIa in children. ''([[ESA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | |||
|} | |||
Revision as of 15:11, 21 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
2013 ESA Guidelines for the Management of Severe Perioperative Bleeding (DO NOT EDIT)[1]
| Class 1 |
| "1. XXXXX. (Level of Evidence: A)" |
| Class 1 |
| "1. XXXXX. (Level of Evidence: A)" |
| Class 2 |
| "1. XXXXX.(Level of Evidence: A)" |
2013 ESA Guidelines for the Management of Severe Perioperative Bleeding (DO NOT EDIT)[1]
Acute Upper Gastrointestinal Bleeding
| Class 1 |
| "1. We recommend that acute variceal bleeding should be managed by a multidisciplinary team. A specific multimodal protocol for upper gastrointestinal hemorrhage should be available. (Level of Evidence: C)" |
| "2. We recommend that early treatment involves immediate use of vasopressors (somatostatin or terlipressin) to reduce bleeding and early interventional endoscopy. Antibiotics must be started on admission. (Level of Evidence: A)" |
| "3. rFVIIa should be used only as rescue therapy; we recommend against its routine use. (Level of Evidence: C)" |
Coagulopathy and Renal Disease
| Class 2 |
| "1. We suggest that conjugated estrogen therapy should be used in uremia.(Level of Evidence: C)" |
| "2. We suggest that desmopressin should be considered for reducing bleeding during surgery and for managing acute bleeding in uremic patients.(Level of Evidence: C)" |
Pediatric Surgery
| Class 1 |
| "1. We recommend against the use of rFVIIa in children. (Level of Evidence: C)" |
Sources
- 2013 ESA Guidelines for the Management of Severe Perioperative Bleeding[1]
References
- ↑ 1.0 1.1 1.2 Kozek-Langenecker, SA.; Afshari, A.; Albaladejo, P.; Santullano, CA.; De Robertis, E.; Filipescu, DC.; Fries, D.; Görlinger, K.; Haas, T. (2013). "Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology". Eur J Anaesthesiol. 30 (6): 270–382. doi:10.1097/EJA.0b013e32835f4d5b. PMID 23656742. Unknown parameter
|month=ignored (help)